Tilray, Inc. (TLRY.TO)
| Previous Close | 8.60 |
| Open | 8.68 |
| Bid | 8.48 x N/A |
| Ask | 8.49 x N/A |
| Day's Range | 8.42 - 8.69 |
| 52 Week Range | 7.99 - 27.88 |
| Volume | |
| Avg. Volume | 1,931,757 |
| Market Cap | 4.029B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.49 |
| Earnings Date | Jan. 10, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Bloomberg
Tilray Rally Fades as Doubts About Pot Stocks Prevail
(Bloomberg) -- Canadian cannabis titan Tilray Inc. fell for a third straight day, surrendering much of a rally posted earlier this week after earnings that were buoyed by acquisitions and a rebranding -- moves aimed at strengthening its global reach in the face of stiff competition at home.Most Read from BloombergDjokovic Loses Shot at Tennis History as Australia Deports StarOne of the World’s Wealthiest Oil Exporters Is Becoming UnlivablePutin’s Troops Wouldn’t Get Cheers in This Once Pro-Russi
- Zacks
After a Downbeat 2021, Will Marijuana ETFs Rebound in 2022?
Cannabis stocks and ETFs were massively downbeat in 2021. However, strong sales backdrop, growing medical usage and still-alive chances of a federal approval may cause a bounce back in pot ETFs in 2022.
- Yahoo Finance Video
Microsoft hires Apple chip veteran, cannabis compounds may prevent COVID infection, TPG prices IPO
Yahoo Finance's Julie Hyman breaks down the leading headlines on Microsoft chip development, a new cannabis study tied to COVID-19, and private equity firm TPG.
